ASBP

ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that its Board of Directors (the "Board") has authorized the repurchase of up to $5.0 million of the Company's common stock. The authorization reflects the Board's confidence in the Company's balance sheet strength, the value of its drug development pipeline and supplement business, and the potential value creation from the recently announced Binding Letter of Intent (LOI) to acquire Dura Driver Control Systems (DCS)."Aspire's strengthened financial position prov

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

Company secures Commitment Letter from a leading financial institution of up to $22.5M to finance proposed acquisition of Dura Control Systems (DCS)LOI to acquire DCS, a leading global automotive supplier with $200M+ in 2025 revenue, is not expected to require new equity raise to consummate the purchase ESTERO, FL / ACCESS Newswire / April 20, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that it has closed the second and final tranche of the private placement announced on February 11, 2026 (the "Offering") for the purchase and sale of 26,250 shares of Series A Convertible Preferred Stock.Pursuant to the closing of the second and final tranc

Elite Ultra-Marathoner targets her second World Record in two months following historicUltra Jackpot 100 Win ESTERO, FL / ACCESS Newswire / April 17, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary, Buzz Bomb Caffeine Company, is proud to announce that elite ultra-marathoner and BUZZ BOMB™ Global Brand Ambassador Ashley Paulson will attempt to shatter the female world record for the fastest 100-mile treadmill run.The historic attempt will take place live at the Boston Marathon Expo at the John B. Hynes Veterans Memorial Convention Center on Saturday, April 18, 2026. This Expo is held in conjunction with the Boston Marathon. Paulson a

8-K/A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

ESTERO, FL / ACCESS Newswire / April 16, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced it has entered into a Letter of Intent (LOI) to acquire Dura Driver Control Systems ("DCS"), a premier designer and manufacturer of automotive driver control systems that also apply to other industrial applications. Management of DCS will be bolstered by the addition of a team from Lakewood & Company with more than 100 years' collective experience within the automotive industry.The proposed acquisition represents a transformative milestone for Aspire and position

Interwest to Drive Regional Growth for BUZZ BOMB™ Across Major Grocery and Convenience ChannelsESTERO, FL / ACCESS Newswire / April 15, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary, Buzz Bomb Caffeine Company, today announced a strategic sales and marketing brokerage agreement with Interwest Brokerage ("Interwest"). This partnership is designed to scale BUZZ BOMB™'s retail footprint across the grocery, convenience, and alternate channel sectors throughout the Intermountain West.Headquartered in Salt Lake City, Interwest is a premier independent Consumer Packaged Goods (CPG) solutions provider known for its high-impact retail execu

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

EFFECT - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

S-1/A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

10-K/A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

10-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

Agreement Set to Expand BUZZ BOMB™ Distribution Across Natural, Specialty, and Mass Merchandiser ChannelsESTERO, FL / ACCESS Newswire / March 19, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, and TruLife Distribution ("TruLife"), announced they have concluded an agreement under which TruLife will manage and coordinate the sales, distribution and merchandising of BUZZ BOMB™ to retailers nationwide.TruLife Distribution is a premier agency known for scaling high-growth health and wellness brands. This relationship is designed to accelerate BUZZ BOMB's retail footprint, specifically targeting the natural, organic, specialty,

ESTERO, FL / ACCESS Newswire / March 17, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, has appointed 25-year industry veteran John Choe as Western Sales Director. Choe joins the leadership team with a distinguished career of scaling consumer brands and leading high-performance teams across the retail and beverage sectors.Choe joins Buzz Bomb following a successful tenure as District Manager at Yerbaé (2016-2025), where he specialized in the natural energy drink category, achieving a 70% increase in overall sales within a highly competitive market. He accomplished this by spearheading the development of brand ambassador p

ESTERO, FL / ACCESS Newswire / March 12, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire"), wholly owned subsidiary, Buzz Bomb Caffeine Company, announces its participation at The Health & Fitness (HFA) Show, scheduled for March 16-18 at the San Diego Convention Center.Aspire will feature its flagship caffeine product, BUZZ BOMB™, at the New Product Zone, a premier area of the event highlighting innovative solutions for the global fitness industry. BUZZ BOMB™, featuring 50mg of caffeine, is a fast-acting dry powder delivered in a single-serving stick pack designed to be sprinkled directly under the tongue. Unlike traditional energy drinks or pills, this serving method allows fo

Convenient Size at the Convenience StoreESTERO, FL / ACCESS Newswire / March 10, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire"), today announced that its subsidiary, Buzz Bomb Caffeine Company, is expanding its retail footprint with the launch of the BUZZ BOMB™ Convenience Store Pack.Convenience stores are where many of today's quick decisions happen, and the checkout counter plays a big role in those moments. By introducing BUZZ BOMB™ into that space, we are giving the consumer greater choice and making BUZZ BOMB™ easier to enjoy and more accessible. This expansion is part of Buzz Bomb Caffeine Company's broader strategy to evolve with people's needs, energize convenience r

Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication.Phase 1 clinical trial of the patent-pending, rapid-onset formulation planned for mid-2026.Alprazolam remains a top 40 prescribed medication in the US, with over 15.8 million prescriptions in 2023.ESTERO, FL / ACCESS Newswire / March 3, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted, patent-pending drug delivery technology, today announced a strategic partnership with Microsize (Quakertown, Pennsylvania), the largest independent North American contract development and manufact

BUZZ BOMB™ captures over 400,000 views and a spike in online revenue driven by strategic brand expansion and Ashley Paulson's historic record at the Jackpot Ultra Running Festival.ESTERO, FL / ACCESS Newswire / February 25, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced a massive expansion of its social media and digital marketing footprint for its wholly owned subsidiary, Buzz Bomb Caffeine Company. The initiative follows a successful strategic rebranding and a high-profile sponsorship of professional ultra-marathoner Ashley Paulson, whose recent world-record performance catalyzed a significant increase in brand visibility and consumer acqu

DEF 14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

Company achieves minimum stockholders' equity rule; Nasdaq confirms matter is closedAspire maintains listing on the NasdaqESTERO, FL / ACCESS Newswire / February 20, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that it had received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum stockholders' equity threshold of $2.5 million under Listing Rule 5550(b)(1). The Company announced on February 10, 2026 that it had received a letter from Nasdaq that the Company had re

ESTERO, FL / ACCESS Newswire / February 19, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary Buzz Bomb Caffeine Company - marketer of a proprietary caffeine supplement - has named ChicExecs as its public relations agency of record.The appointment comes as BUZZ BOMB™ gears up for a transformative year focused on aggressive brand expansion, product innovation, and a refreshed market presence. ChicExecs, a powerhouse agency with offices in six states and a portfolio of over 250 global brands, will spearhead BUZZ BOMB™'s communications strategy. The focus includes media relations, high-impact events, strategic partn

S-1 - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)